Lafragette chateaux sold
Get our daily fine wine reviews, latest wine ratings, news and travel guides delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Sales of Jean-Paul Lafragette’s Bordeaux chateaux are now almost complete.
The former director of L&L is under investigation for misappropriation of company funds.
The sales of two of his three properties – Château de Rouillac in Pessac Leognan and Château de l’Hospital in Graves – are both due to be finalised in the next few days.
The family’s third château, the 42ha Loudenne in the Medoc, will not be sold.
Lafragette has also sold 49% of his shareholding in his company L&L. The civil case against Lafragette taken by the Kobrand company will now be dropped.
‘The sale, yesterday, July 31st, of his shares in L&L to Kobrand puts an amicable end to all litigation between L&L and Lafragette,’ said family lawyer Olivier Guidoux.
Lafragette could still be prosecuted independently by the French government.
Get our daily fine wine reviews, latest wine ratings, news and travel guides delivered straight to your inbox.
Guidoux would not comment on the value of the sale of the L&L shares, nor on the value of the chateaux sales or who the new owners are.
Sources in Bordeaux estimate that the 17ha Chateau de Rouillac fetched around €7.5m. The buyers are said to be ‘two young cereal farmers’.
The sale value of Chateau l’Hospital, 12ha, was estimated at about €2.5m.
Written by Sophie Kevany in Bordeaux

Sophie Kevany is a freelance journalist, editor and researcher who is based in Bordeaux, France.
For Decanter, she reports on the news in Bordeaux, as well as covering various areas of the world wine industry such as environmentalism and reporting on wine markets.
She has formerly written for Agence France-Press, Dow Jones Newswires and the Profitable Ideas Exchange in Bordeaux.